Sensei Biotherapeutics, Inc.
ROCKVILLE, MD · CIK 0001829802 · Biotech · Public
Small molecule inhibitors targeting the PI3K/AKT/mTOR signaling pathway
faeththerapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $349M
- 1 Form D · Mar 2026
- 7 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 17
- 1 granted · 16 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $348,906,500 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2780 | Tentarix | — | — |
| 2781 | Instil Bio, Inc. | — | $371M |
| 2782 | Legend Biotech Corp | — | $350M |
| 2783 | Sensei Biotherapeutics, Inc. | — | $349M |
| 2784 | X4 Pharmaceuticals | — | $313M |
| 2785 | Nuvation Bio | — | $275M |
| 2786 | CELL REPROGRAMMING & THERAPEUTICS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Josiah CraverExecutive Officer
- Phillip DonenbergDirector
- Christopher GerryDirector · Executive Officer
- Bob HolmenDirector
- Kristian HumerDirector
- Anand ParikhDirector · Executive Officer
- Tom RicksDirector
Patents
- Modified Antibodies And Related Compounds, Compositions And Methods Of Usegranted
- Anti-vista Antibodies And Uses Thereofapplication
- Combination Therapies For Cancerapplication
- Compositions And Methods For Manufacturing Bacteriophage Cancer Vaccines And Uses Thereofapplication
- Aspartate Beta-hydroxylase Chimeric Antigen Receptors And Uses Thereofapplication
- Compositions And Methods For Manufacturing Bacteriophage Cancer Vaccines And Uses Thereofapplication
- Aspartate Beta-hydroxylase Chimeric Antigen Receptors And Uses Thereofapplication
- Combination Therapies For Cancerapplication
- Compositions And Methods For Manufacturing Bacteriophage Cancer Vaccinesapplication
- Aspartate Beta-hydroxylase Chimeric Antigen Receptors And Uses Thereofapplication
- Compositions And Methods For Manufacturing Bacteriophage Cancer Vaccinesapplication
- Bispecific Anti-vista And ANTI-CD28 Binding Proteins And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.